Hattie Hayes

The framework covers ocular hypertension to severe progression

In the second of two video interviews from the International SPECTRALIS Symposium, Prof Malik emphasises the importance of corneal imaging

Prof Baljean Dhillon advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium

Anat Loewenstein, MD, presented real-world results of remote imaging at the International SPECTRALIS Symposium

Dinah Zur, MD, shares insights from her International SPECTRALIS Symposium lecture

Dr Brunstetter, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, delivered the lecture at this year's ISS alongside his colleague Warren Hoburg

Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS, presented two studies involving the EZ line at this year’s International SPECTRALIS Symposium

Ophthalmologists may be “at the forefront of a revolution in healthcare,” the nephrology professor said at this year’s International SPECTRALIS Symposium

The new technology will be crucial to imaging retinal function in the future, Prof Hüttmann predicted at the International SPECTRALIS Symposium

Prof Malik shared his presentation, titled "An eye on neurodegenerative diseases: Challenging the dogma," at this year's International SPECTRALIS Symposium

Prof Hogg presented a wide breadth of research at the International SPECTRALIS Symposium

More than 35 lectures across seven topics, plus a keynote address, will be featured during the meeting

Research findings from the multicentre clinical study were presented at the European Society of Ophthalmology (SOE) meeting in Lisbon, Portugal

Special programming for young ophthalmologists will be hosted in the YO lounge

This year’s multi-specialty programme features the SOE Leadership Development Programme (EuLDP), the International Society of Ocular Trauma (ISOT), European University Professors of Ophthalmology (EUPO) and more

The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.

The Optegra platform currently operates in the Czech Republic, the Netherlands, Poland, Slovakia and the United Kingdom

New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol

At the 2025 ASCRS meeting, Dr Ang said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery

Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia

Detecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia

The company shared results from the AAVB-081 clinical programme and AAVB-039 preclinical programme at ARVO

The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia

At the 2025 ARVO annual meeting, Prof Sadun shared an exciting update in our understanding of Leber hereditary optic neuropathy

Prof Loewenstein and a cohort of colleagues assessed the current treatment outlook for patients with diabetic retinopathy

In the weeks to come, the European Commission will issue a decision on the first severe thyroid eye disease treatment

Endoscopic cyclophotocoagulation (ECP) has major potential for patients with glaucoma

According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.

The US Food and Drug Administration did not identify any safety or efficacy issues associated with aflibercept 8 mg